Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

3,4-Dihydroxyphenylglycolaldehyde

From Wikipedia, the free encyclopedia
Neurotransmitter metabolite and neurotoxin
3,4-Dihydroxyphenylglycolaldehyde
Names
IUPAC name
2-(3,4-dihydroxyphenyl)-2-hydroxyacetaldehyde
Other names
DHMAL; 3,4-Dihydroxyphenylglycolaldehyde; 3,4-Dihydroxyphenylglycol aldehyde; DOPEGAL; DOPGAL; DHPGALD; Norepinephrine aldehyde; Epinephrine aldehyde; Noradrenaline aldehyde; Adrenaline aldehyde
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
KEGG
  • InChI=1S/C8H8O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-4,8,10-12H
    Key: YUGMCLJIWGEKCK-UHFFFAOYSA-N
  • C1=CC(=C(C=C1C(C=O)O)O)O
Properties
C8H8O4
Molar mass168.148 g·mol−1
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL), also known as3,4-dihydroxymandelaldehyde (DHMAL) as well asnorepinephrine aldehyde orepinephrine aldehyde, is ametabolite of themonoamine neurotransmittersnorepinephrine andepinephrine. DOPEGAL is anoradrenergic neurotoxin.[1]

Formation

[edit]
Formation of DOPEGAL (norepinephrine aldehyde) fromnorepinephrine.[2]

DOPEGAL is formed bymonoamine oxidase (MAO) viaoxidativedeamination.[3][4][5][6][7][8] Following its formation, DOPEGAL ismetabolized. Through the metabolism process, it is converted into3,4-dihydroxymandelic acid (DHMA) viaaldehyde dehydrogenase (ALDH), or into3,4-dihydroxyphenylglycol (DHPG) viaaldehyde reductase (ALR).[2][4][5][6][7]

See also

[edit]

References

[edit]
  1. ^Marchitti SA, Deitrich RA, Vasiliou V (June 2007). "Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase".Pharmacol Rev.59 (2):125–150.doi:10.1124/pr.59.2.1.PMID 17379813.
  2. ^abFigure 11-4 in:Flower, R.; Rang, H. P.; Dale, M. M.; Ritter, J. M. (2007).Rang & Dale's Pharmacology. Edinburgh: Churchill Livingstone.ISBN 978-0-443-06911-6.
  3. ^"3,4-Dihydroxymandelaldehyde".PubChem. Retrieved8 September 2024.
  4. ^abGoldstein DS (February 2020)."The catecholaldehyde hypothesis: where MAO fits in".J Neural Transm (Vienna).127 (2):169–177.doi:10.1007/s00702-019-02106-9.PMC 10680281.PMID 31807952.
  5. ^abTipton KF (November 2018). "90 years of monoamine oxidase: some progress and some confusion".J Neural Transm (Vienna).125 (11):1519–1551.doi:10.1007/s00702-018-1881-5.PMID 29637260.
  6. ^abBortolato M, Shih JC (2011)."Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence".Int Rev Neurobiol. International Review of Neurobiology.100:13–42.doi:10.1016/B978-0-12-386467-3.00002-9.ISBN 978-0-12-386467-3.PMC 3371272.PMID 21971001.
  7. ^abKawamura M, Eisenhofer G, Kopin IJ, Kador PF, Lee YS, Tsai JY, Fujisawa S, Lizak MJ, Sinz A, Sato S (August 1999). "Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats".Biochem Pharmacol.58 (3):517–524.doi:10.1016/s0006-2952(99)00121-5.PMID 10424772.
  8. ^Kawamura M, Eisenhofer G, Kopin IJ, Kador PF, Lee YS, Fujisawa S, Sato S (March 2002). "Aldose reductase: an aldehyde scavenging enzyme in the intraneuronal metabolism of norepinephrine in human sympathetic ganglia".Auton Neurosci.96 (2):131–139.doi:10.1016/s1566-0702(01)00385-x.PMID 11958479.
Catecholamines
Anabolism
Catabolism
Dopamine
Norepinephrine
Epinephrine
TryptophanSerotonin
Anabolism
Catabolism
SerotoninMelatonin
Trace amines
Histamine
GABA
Dopaminergic
Noradrenergic
Serotonergic
Unsorted
Retrieved from "https://en.wikipedia.org/w/index.php?title=3,4-Dihydroxyphenylglycolaldehyde&oldid=1245719134"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp